Institutional Clinical and Translational Science Award

联系PD/PI：Fitzgerald，Garret A NRSA-Training-001(234) 核心J：机构培训核心 项目摘要/摘要 宾夕法尼亚大学(Penn)TL1提案的目标和意义与国家 社会需要显著提高临床和转化科学(CTS)。这其中的一个关键组成部分 目标是培养这一领域的下一代研究带头人。正如我们的CTSA所表达的那样 提案中，宾夕法尼亚州立大学致力于全力以赴推进翻译科学，由美国翻译研究所领导 翻译医学和治疗(ITMAT)，并在此范围内实现TL1的首要目标 我们的受训人员具有意识、技能和资源，这将使他们在CTS的实施中脱颖而出。 申请10个博士后和10个博士后名额，以支持TL1奖学金获得者 证书(1年)或硕士学位(2-3年)专门为CTS开发的课程。的结构 宾夕法尼亚大学的TL1建立在宾夕法尼亚大学杰出的毕业生和博士后基础上，并与之无缝集成 研究生课程，但认识到翻译科学需要独特的额外知识和 一整套技能。博士前学者将从宾夕法尼亚大学的博士、医学/博士和VMD/博士研究项目中挑选出来 以及MD、VMD、DMD和MNS临床培训计划。同样，博士后学者将被选为 来自宾夕法尼亚大学杰出的临床(MD、VMD、DMD)住院医师和研究员，以及研究(博士)研究员。 TL1计划的主要目标是： ·通过提高认识和个人评估，招募有才华和忠诚的受训人员； ·制定有指导的个性化实习生教育计划，既要训练特定技能，又要 专业能力； ·培养基本科学技能，并在临床和翻译方面进行指导性研究 科学； ·翻译科学新兴领域的高级培训方案； ·增强受训人员的专业技能组合，以促进职业发展 通过创建新的知识范式，学者们得到了创新的跨学科桥梁的支持 翻译，通过提供出色的翻译研究设施和核心，并通过积极的咨询和 指导-始终着眼于最高的道德标准，翻译的基本租户， 是什么将我们的受训人员团结为同事，以及我们的培训计划和TL1奖项作为 单一实体，而不仅仅是元素的集合。TL1通过有效使用将时间到度数降至最低 选修课和课余时间的在线教学。TL1强调个体的发展 专业发展计划，以支持多样化的职业偏好。重要的是，该计划也是 再加上强大的多样性和包容性努力，以及专门的指导计划。 总而言之，宾夕法尼亚大学的TL1/CTSA方法直接涉及CTSA的五个关键目标中的每一个，并在此基础上 具有严谨、广度、灵活性和个性的卓越表现。这个教育项目是由天才领导的。 和经验丰富的联合计划主任，TL1奖项与CTSA-U和KL2无缝结合 奖励组成部分。重要的是，TL1奖是宾夕法尼亚大学唯一支持Pre和Pre的专门机制 CTS的博士后学者。 项目摘要/摘要页1102 联系PD/PI：Fitzgerald，Garret A NRSA-Training-001(234) OMB号码：4040-0001 到期日：2016/06/30 研究与相关高级/关键人员简介(扩展) -- 简介-项目总监/首席调查员 前缀：名字*：格伦中间名：N.姓氏*：*高顿后缀：* 职位/头衔*：A教授 组织名称*：宾夕法尼亚大学 部门： 部门： Street1*：宾夕法尼亚大学 STREET2：病理与检验医学系 城市*：费城 县： 州*：宾夕法尼亚州 省： 国家*：美国：美国 邮政编码*：191046082 电话号码*：(215)传真号码：(212)573-7945电子邮件*：Gaulton@MAIL.MED.UPENN.EDU 898-2874 凭证，例如，机构登录：Gaulton 项目角色*：其他(指定)其他项目角色类别：核心领导 学位类型：理科博士，理科学士学位年份：大学 _文件名Mime类型 附上个人素描*：GaultonG_Biosketch_CTSA_2015.pdf 应用程序/pdf 附加当前待定支持(&P)： -- 第1103页 跟踪编号：GRANT11998683资助机会编号：PAR-15-304。收到日期： 2015-09-24T11：44：37.000-04：00

Contact PD/PI: FITZGERALD, GARRET A NRSA-Training-001 (234) Core J: Institutional Training Core PROJECT SUMMARY/ABSTRACT The goal and significance of the University of Pennsylvania (Penn) TL1 proposal is matched to both a national and societal need to dramatically enhance clinical and translational science (CTS). A key component of this goal is to train the next generation of research leaders of this domain. As expressed throughout our CTSA proposal, Penn is committed “all-in” to the advancement of translational science, led by the Institute for Translation Medicine and Therapeutics (ITMAT), and within this to achieve the overarching TL1 goal of arming our trainees with the awareness, skills and resources that will position them to excel in the conduct of CTS. Ten pre-doctoral and ten post-doctoral slots are requested to support TL1 Scholars who will enroll in either Certificate (1year) or Master degree (2-3year) programs developed specifically for CTS. The structure of Penn's TL1 builds synergistically upon and integrates seamlessly with Penn's outstanding graduate and post- graduate programs, but recognizes that translational science requires a distinctive, additional knowledge and skill set. Pre-doctoral Scholars will be selected from Penn's PhD, MD/PhD and VMD/PhD research programs and MD, VMD, DMD and MNS clinical training programs. Similarly, post-doctoral Scholars will be selected from Penn's outstanding clinical (MD, VMD, DMD) residents and fellows, and research (PhD) fellows. The primary objectives of the TL1 program are: • Recruit talented and committed trainees by promoting awareness and individual assessment; • Develop mentored personalized trainee educational plans targeted both to discipline specific skills and professional competencies; • Develop fundamental scientific skills and conduct mentored research in clinical and translational science; • Advance training programs in emerging areas of translational science; • Augment aligned professional skill sets of trainees to bolster career progression Scholars are supported by innovative cross-discipline bridges, by creating new knowledge paradigms for translation, by providing outstanding translational research facilities and cores, and through active advising and mentorship – always with an eye toward the highest ethical standards, the essential tenants of translation, what unites our trainees as colleagues, and what distinguishes our training program and the TL1 award as a singular entity, rather than a mere collection of elements. The TL1 minimizes time-to-degree by effective use of elective units and off-hours online instruction. The TL1 emphasizes the development of individual professional development plans to support diverse career preferences. Importantly, the program is also coupled to a robust diversity and inclusion effort, and a dedicated mentoring program. In summary, Penn's TL1/CTSA approach speaks directly to each of the five key CTSA goals and builds upon existing excellence with rigor, breadth, flexibility and individuality. The educational program is led by talented and experienced Co-Program Directors and the TL1 award is seamlessly integrated with the CTSA-U and KL2 award components. Importantly, the TL1 award is the only dedicated mechanism at Penn to support pre and post-doctoral scholars in CTS. Project Summary/Abstract Page 1102 Contact PD/PI: FITZGERALD, GARRET A NRSA-Training-001 (234) OMB Number: 4040-0001 Expiration Date: 06/30/2016 RESEARCH & RELATED Senior/Key Person Profile (Expanded)   PROFILE - Project Director/Principal Investigator Prefix:  First Name*: Glen Middle Name N. Last Name*: Gaulton Suffix:  Position/Title*: PROFESSOR A Organization Name*: University of Pennsylvania Department: Division: Street1*: UNIVERSITY OF PENNSYLVANIA Street2: DEPT OF PATHOLOGY & LAB MEDICINE City*: PHILADELPHIA County: State*: PA: Pennsylvania Province: Country*: USA: UNITED STATES Zip / Postal Code*: 191046082 Phone Number*: (215) Fax Number: (212) 573-7945 E-Mail*: GAULTON@MAIL.MED.UPENN.EDU 898-2874 Credential, e.g., agency login: gaulton Project Role*:  Other (Specify) Other Project Role Category: Core Lead Degree Type:  PHD,BS Degree Year:    File Name Mime Type Attach Biographical Sketch*: GaultonG_Biosketch_CTSA_2015.pdf application/pdf Attach Current & Pending Support:   Page 1103 Tracking Number: GRANT11998683 Funding Opportunity Number: PAR-15-304 . Received Date: 2015-09-24T11:44:37.000-04:00